TREATING C3 GLOMERULOPATHY WITH ECULIZUMAB

Abstract Background C3 glomerulopathy (C3G) is a rare, but severe glomerular disease with grim prognosis.The complex pathogenesis is just unfolding, and involves acquired as well as inherited dysregulation of the alternative pathway of the complement cascade.Currently, there is no established therapy.Treatment with the C5 complement inhibitor eculi

Cyber-Physical Systems (CPSs) are becoming increasingly complex and interconnected as they attempt to meet the demands of evolving society.As a result, monitoring and maintaining them becomes a more complex and demanding task for control system operators and cyber revlon colorstay lip liner plum defenders.While the literature on visualization techn